PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Format:	Artikel
Sprache:	Russian
Veröffentlicht:	Remedium Group LLC 2017-11-01
Schriftenreihe:	Медицинский совет
Schlagworte:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
Online Zugang:	https://www.med-sovet.pro/jour/article/view/2007

Ähnliche Einträge

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
von: Annina S. Vischer, et al.
Veröffentlicht: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
von: Chinonyerem O. Iheanacho, et al.
Veröffentlicht: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
von: Piotr Skonieczny, et al.
Veröffentlicht: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
von: Yang Zhao, et al.
Veröffentlicht: (2018-01-01)

Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
von: Chibuike C. Udenigwe, et al.
Veröffentlicht: (2014-05-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
von: Kuang-Ming Liao, et al.
Veröffentlicht: (2023-11-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
von: N.D. Filipets, et al.
Veröffentlicht: (2019-02-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
von: Jordan Loader, et al.
Veröffentlicht: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
von: Simon B. Gressens, et al.
Veröffentlicht: (2021-02-01)

Angiotensins and rheumatoid arthritis
von: N. M. Savushkina, et al.
Veröffentlicht: (2019-01-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
von: JungMin Choi, et al.
Veröffentlicht: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
von: Leonard K. Wang, et al.
Veröffentlicht: (2023-06-01)

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
von: Fabrizio Buffolo, et al.
Veröffentlicht: (2021-05-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
von: N. V. Drobotya, et al.
Veröffentlicht: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
von: Yipeng Fang, et al.
Veröffentlicht: (2024-08-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
von: Jilong XU, et al.
Veröffentlicht: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
von: Anna V. Aksenova, et al.
Veröffentlicht: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
von: S. V. Stolov
Veröffentlicht: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
von: Konstantinos Tziomalos, et al.
Veröffentlicht: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
von: T E Morozova
Veröffentlicht: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
von: K. A. Ghyamdzhyan, et al.
Veröffentlicht: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
von: Stine Andersen, et al.
Veröffentlicht: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
von: S Ravitej, et al.
Veröffentlicht: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
von: Hye-Jin Park, et al.
Veröffentlicht: (2022-01-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
von: Steven M. Smith, et al.
Veröffentlicht: (2023-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
von: Ann Z. Bauer, et al.
Veröffentlicht: (2021-01-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
von: Joachim Beige
Veröffentlicht: (2019-06-01)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
von: José A. Carlos-Escalante, et al.
Veröffentlicht: (2021-05-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
von: Maksimov M.L., et al.
Veröffentlicht: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
von: M L Maksimov, et al.
Veröffentlicht: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
von: Hany A Al-Hussaniy, et al.
Veröffentlicht: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
von: Yohko Nagai, et al.
Veröffentlicht: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
von: M L Maksimov
Veröffentlicht: (2010-06-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
von: Kamryn E. Jones, et al.
Veröffentlicht: (2024-06-01)

Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)
von: D.D. Ivanov, et al.
Veröffentlicht: (2021-09-01)

Dataset for discovering new hypertension small molecules using machine learning-aided computational fragment-based design
von: Odifentse Mapula-e Lehasa, et al.
Veröffentlicht: (2024-08-01)

Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
von: Mishita Goel, et al.
Veröffentlicht: (2020-08-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
von: A. E. Bragina, et al.
Veröffentlicht: (2005-12-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
von: Tao Liu, et al.
Veröffentlicht: (2023-01-01)

Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer
von: Marcin Zeman, et al.
Veröffentlicht: (2022-07-01)